GLP-1 for Athletes: My Journey to Race Weight

A triathlete documents his GLP-1 journey on tirzepatide — body composition data, weight tracking, dosage protocol, side effects, and training outcomes.

Endurance athlete documenting GLP-1 journey to race weight with training data
Endurance athlete documenting GLP-1 journey to race weight with training data

Protocol Timeline — Key Events

  1. Feb 20 First injection
    (2.5 mg tirzepatide)
  2. Feb 22 Start weight
    95.8 kg
  3. Mar 22 Low point 89.0 kg
    (−6.8 kg)
  4. Mar 27 End of 5-week
    protocol
  5. Late Mar Dose cut to
    20 units
  6. Apr 11 Week 9 — hunger
    back, small binges

Why This Question Is Suddenly Everywhere

GLP-1 medications are on the verge of going mass. Morgan Stanley projects the number of Americans on GLP-1s will quadruple over the next decade — from roughly 13 million at end of 2025 to 55 million by 2035, about 15% of the US population. A KFF survey already found 12% of US adults (~30 million people) saying they were currently taking a GLP-1 drug. The gap between those numbers comes mostly from the booming compounded market — people getting prescriptions through Hims, telehealth clinics, and online pharmacies that don't show up in pharma sales data.

The next wave will be larger. Lower prices from generics and compounders, new pill-based formulations that require no weekly injection, and expanded Medicare coverage are all converging in 2026–2027. This is no longer a niche question for diabetics or the severely obese. It's becoming a mainstream tool — and endurance athletes are ahead of the curve, already asking the practical questions that matter: Can I train on this? Will it ruin my race fueling? Will I lose muscle? That's exactly what I documented.

Why I Started GLP-1

In early 2026 I was deep in Ironman prep for Challenge Roth (July 2026) and running multiple marathons a year. Training weeks regularly hit 15–20 hours, and the hunger that comes with that volume is relentless. The loop was always the same: train hard, get ravenous, overeat, undo the deficit. Ironman training did not solve it. It made it worse.

I also have a lifelong sensitivity to sugar. Childhood sugar binges, emotional eating when stress is high, the kind of pattern that doesn't go away, it just waits. This is not a clinical obesity story. I started around 96 kg and wanted to get to a real race weight, where watts per kilo actually changes what I can do on the bike and what the last 10 km of a marathon feels like. Willpower had failed me for years. Every training block I'd get leaner for a while, then the appetite would win.

The doctor conversation was short. He prescribed tirzepatide (Mounjaro) 5 mg KwikPen at 2.5 mg per week — the starter dose. Not long-term maintenance. A tool to break the hunger loop during the heaviest training block and get me to race weight before the season started. First injection went in on February 20, 2026.

My Protocol

  • Medication: Tirzepatide (Mounjaro) 5mg KwikPen
  • Dose: 2.5mg per week (30 units) for weeks 1-6, reduced to ~1.67mg (20 units) from week 7
  • Injection day: Fridays at 19:30 — evening before bed, to sleep through any potential side effects
  • Start date: February 20, 2026
  • Initial protocol end: March 27, 2026 (5 weeks)
  • Continuation: Reduced to 20 units from late March — ongoing as of April 8

The plan was always 5 weeks, not indefinite use. Break the hunger loop in the heaviest training block, build habits that would carry after stopping, get into Ironman season at race weight. That was the theory.

Monitoring: weekly circumferences (weight, waist, belly, chest, hips, thighs), body fat and lean mass estimated from those numbers via a linear regression model, blood work before and after the protocol.

Weight Timeline

All measurements taken at the same time of day, tracked in my athlete tracking system. Numbers below are the raw measurement data.

Date Weight (kg) Notes
Jan 18, 2026 94.1 Pre-protocol baseline
Feb 16, 2026 96.4 Last measurement before GLP-1 start
Feb 20, 2026 First tirzepatide injection (2.5 mg, 30 units)
Feb 22 95.8 Week 1
Mar 1 94.9 Week 2
Mar 7 93.2 Week 3
Mar 16 92.0 Week 4
Mar 22 89.0 Week 5 — low point at full dose
Mar 29 90.2 Week 6 — protocol officially ended Mar 27
Apr 6 93.6 Week 8 — 2 weeks at reduced dose (20 units)
Apr 11 Week 9 — lower dose, hunger clearly returning, small binges

Weight swings 2–3 kg day to day with hydration, training load and meal timing, so the trend matters more than any single reading. Lowest weigh-in was 89.0 kg on Mar 22 at the full 30-unit dose. Two weeks after cutting to 20 units I was back at 93.6 kg on April 6, and this week (week 9) hunger is noticeably sharper than it was at full dose. The suppression is weaker, the window before the next injection feels longer, and for the first time on this protocol I've had a few small binges. Honest bit: alcohol made it worse. Evenings with a drink or two, the brakes came off and portions went sideways in a way that simply did not happen at 30 units. The old childhood pattern — emotional eating, sugar sensitivity — is still there. The lower dose just stopped covering for it. That's what I'm weighing right now: return to the full dose, or accept a slower rate of progress and work on the habits directly. More on the appetite-alcohol-binge dynamic in the sugar cravings update.

Body Composition

No DEXA scan access locally, so body-comp tracking is weekly circumference measurements run through a linear regression model for body fat and lean mass. Not perfect. Consistent enough to trend.

Body fat estimates: 13.0% (Feb 22) → 11.3% (Mar 22, low point) → 11.6% (Apr 6, reduced dose).

Lean mass estimates: 83.3 kg (Feb 22) → 78.9 kg (Mar 22). This is the number I keep staring at. About 4 kg of estimated lean mass came off alongside the fat, even with full resistance work and high protein intake. So much for "muscle preservation happens on its own." It's active work, and I was doing all of it, and I still lost lean mass.

Measurement Start (Feb 22) Low (Mar 22) Current (Apr 6) Δ start → low
Weight (kg) 95.8 89.0 93.6 −6.8
Waist (cm) 87.5 85.5 84.5 −2.0
Belly button (cm) 86.0 82.5 83.0 −3.5
Chest (cm) 99.5 100.0 100.0 +0.5
Glutes (cm) 104.0 102.0 103.0 −2.0
Left leg (cm) 63.0 62.0 63.0 −1.0
Right leg (cm) 64.0 62.5 63.5 −1.5
Left arm (cm) 39.5 38.3 39.5 −1.2
Right arm (cm) 40.0 39.0 40.5 −1.0
Body fat (%) 13.0 11.3 11.6 −1.7

Pattern: trunk loss dominates. Waist down 2 cm, belly button down 3.5 cm, chest basically flat. Limbs moved 1–1.5 cm at the low point and most of that came back as weight rebounded, which fits glycogen and water swings better than actual leg-tissue loss. Subjectively I still look and feel leaner, and the waist is still ticking down even as weight goes back up.

Race Results — Baseline & Upcoming

Context: every marathon result below is pre-GLP-1. Baseline performances at various weights. The first races I'll run at the new weight are still ahead.

Race Date Time Weight Notes
Shanghai Marathon Nov 2024 3:49:47 95.3 kg
Metropolis Marathon Feb 2025 3:23:41 92 kg Personal best
Berlin Marathon Sep 2025 3:55:07 92 kg Hot conditions
Valencia Marathon Dec 2025 3:51:01 95 kg

Upcoming — first races at new weight:

  • IM 70.3 Da Nang (May 10, 2026) — my first triathlon race at the lower weight
  • Challenge Roth (July 6, 2026) — full Ironman, the primary target for this entire journey

This page will be updated with race data, split analysis, and power numbers as these events are completed.

For detailed split analysis and Garmin data from past races, see my full race results breakdown.

What Actually Changed

The number I care about most on the bike is watts per kilogram. Across the 5 weeks my FTP went from 261W to 281W, a 20-watt gain (+7.7%). Combined with the weight loss, my W/kg went from 2.76 to 3.04. A 10% jump. On a hilly Ironman course, that's real.

I want to be careful with attribution here. The FTP gains could easily be down to structured training — I was in a dedicated build phase with intervals and threshold work, and that alone adds 10-15 watts in a 5-week block if you do it right. The weight loss and body-comp changes are clearly the medication. The appetite suppression broke the loop where training hunger would always blow up the deficit.

The clear wins were body comp, power-to-weight, and how I actually feel running. Training volume held (no missed sessions), in-session energy held, sleep and recovery held. The one thing I can't separate cleanly is how much of the FTP gain was the weight loss and how much was a well-structured build phase. Probably both, in some ratio I'll never know exactly, and I'm fine with that.

Side Effects

First injection was during the day (Feb 20). I was nauseous for a couple of hours afterwards. That was the only time. Every injection after that went in Friday at 19:30, right before bed, and the side-effect profile was zero. The trick was simple: inject in the evening, sleep through the window where GI stuff might show up, wake up normal.

No energy dips in training, no GI issues on long rides or runs, no hit to sleep or recovery. The appetite suppression did exactly what it was supposed to do: cravings dropped, hunger was manageable, and the post-big-session urge to eat the kitchen was gone for most of the week.

One pattern stood out. Suppression is strongest days 1–5 post-injection. By days 6–7, hunger starts creeping back before the next dose. Manageable, but noticeable.

I also got lucky. Plenty of athletes report serious GI issues, especially during dose titration. The starter dose (2.5 mg tirzepatide) plus evening timing probably helped a lot. Your experience may look nothing like mine. This is a sample size of one.

For the full protocol on managing side effects around training, see my side effects and dose timing guide.

Deep Dives & Resources

Frequently Asked Questions

Can you train for a marathon or Ironman while on Ozempic or Wegovy?

Yes — I maintained full training volume throughout my GLP-1 protocol (tirzepatide/Mounjaro), including Ironman and marathon preparation. The key adaptations were adjusting fueling strategy (GLP-1 slows gastric emptying), timing injections on Friday evenings to minimize side effects, and prioritizing protein intake to preserve lean mass. I did not miss a single training session due to the medication.

Does semaglutide (Ozempic, Wegovy) affect running performance?

In my experience, the net effect was positive due to improved power-to-weight ratio — my W/kg went from 2.76 to 3.04 over 5 weeks. However, it is hard to isolate GLP-1 from general training progression. The performance benefit comes from the weight loss itself, not from the medication directly affecting athletic capacity. I had to actively manage fueling and muscle preservation throughout.

How do you fuel long runs and races on GLP-1?

GLP-1 slows gastric emptying, which means gels and carbohydrates take longer to absorb. I adjusted by starting fueling earlier in long sessions, using more liquid calories (which absorb faster), and testing every nutrition change during training before race day. I cover this in detail in my race day fueling guide.

Is semaglutide (Ozempic) banned by WADA for competitive athletes?

As of 2026, semaglutide is on WADA's monitoring program but is NOT on the prohibited list. It is legal for use in competition across all sports. However, WADA is actively studying it and could move it to the banned list in future years. I discuss the ethics and regulatory landscape in my WADA analysis.

How do you prevent muscle loss on Ozempic or Mounjaro as an endurance athlete?

Studies show 25-40% of weight lost on GLP-1 can be lean mass without intervention. My protocol included full body resistance training throughout, high protein intake, and maintaining training volume. Circumference measurements showed fat loss concentrated in the trunk while limb measurements stayed stable, suggesting good muscle preservation. The full protocol is in my muscle preservation guide.

Used by 50,000+ athletes

Ready to Train Smarter?

Get personalized training zones, race predictions, and performance insights with our free calculators.